drug
isavuconazonium sulfate
Marketedupdated 5mo agoby Astellas Pharma US Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(1)
Trials studying isavuconazonium sulfate
- phase2A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants
- phase1A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants
- phase1A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
- —Registry of Patients Treated With Systemic Mold-Active Triazoles
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 8, 2026
58 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (14)
- Mar 14, 2028patentUS 10206879*PED1.4y
- Mar 14, 2028patentUS 10206879*PED1.4y
- Mar 14, 2028patentUS 10603280*PED1.4y
- Mar 14, 2028patentUS 10603280*PED1.4y
- Sep 14, 2027formulationUS 10206879338d
- Sep 14, 2027formulationUS 10206879338d
- Sep 14, 2027formulationUS 10603280338d
- Sep 14, 2027formulationUS 10603280338d
- Apr 30, 2026patentUS 6812238*PED
- Apr 30, 2026patentUS 6812238*PED
- Apr 30, 2026patentUS 6812238*PED
- Oct 31, 2025compositionUS 6812238
- Oct 31, 2025compositionUS 6812238
- Oct 31, 2025compositionUS 6812238
FDA exclusivities (26)
- Jun 8, 2031PEDPediatric (6mo bonus)4.7y
- Jun 8, 2031PEDPediatric (6mo bonus)4.7y
- Jun 8, 2031PEDPediatric (6mo bonus)4.7y
- Dec 8, 2030ODE-454Orphan Drug (7y)4.2y
- Dec 8, 2030ODE-458Orphan Drug (7y)4.2y
- Dec 8, 2030ODE-458Orphan Drug (7y)4.2y
- Dec 8, 2030ODE-454Orphan Drug (7y)4.2y
- Dec 8, 2030ODE-453Orphan Drug (7y)4.2y
- Dec 8, 2030ODE-459Orphan Drug (7y)4.2y
- Sep 6, 2027GAINGAIN Antibiotic (5y)330d
- Sep 6, 2027GAINGAIN Antibiotic (5y)330d
- Sep 6, 2027GAINGAIN Antibiotic (5y)330d
- Jun 8, 2027PEDPediatric (6mo bonus)240d
- Jun 8, 2027PEDPediatric (6mo bonus)240d
- Jun 8, 2027PEDPediatric (6mo bonus)240d
- Dec 8, 2026NPPNew Product (3y)58d
- Dec 8, 2026NPPNew Product (3y)58d
- Dec 8, 2026NPPNew Product (3y)58d
- Sep 6, 2022PEDPediatric (6mo bonus)
- Sep 6, 2022PEDPediatric (6mo bonus)
- Sep 6, 2022PEDPediatric (6mo bonus)
- Mar 6, 2022ODE*ODE*
- Mar 6, 2022ODE-90Orphan Drug (7y)
- Mar 6, 2022ODE-305Orphan Drug (7y)
- Mar 6, 2022ODE-90Orphan Drug (7y)
- Mar 6, 2022ODE-305Orphan Drug (7y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that